Cargando…
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
Developing patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cance...
Autores principales: | Kohli, Manish, Wang, Liguo, Xie, Fang, Sicotte, Hugues, Yin, Ping, Dehm, Scott M., Hart, Steven N., Vedell, Peter T., Barman, Poulami, Qin, Rui, Mahoney, Douglas W., Carlson, Rachel E., Eckel-Passow, Jeanette E., Atwell, Thomas D., Eiken, Patrick W., McMenomy, Brendan P., Wieben, Eric D., Jha, Gautam, Jimenez, Rafael E., Weinshilboum, Richard, Wang, Liewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687867/ https://www.ncbi.nlm.nih.gov/pubmed/26695660 http://dx.doi.org/10.1371/journal.pone.0145176 |
Ejemplares similares
-
A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens
por: Jimenez, Rafael E., et al.
Publicado: (2019) -
Measure transcript integrity using RNA-seq data
por: Wang, Liguo, et al.
Publicado: (2016) -
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer
por: Hart, Steven N, et al.
Publicado: (2016) -
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment
por: Sicotte, Hugues, et al.
Publicado: (2022) -
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
por: Ellingson, Marissa S., et al.
Publicado: (2015)